A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity.
about
Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver.Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure.Interleukin-1 inhibition facilitates recovery from liver injury and promotes regeneration of hepatocytes in alcoholic hepatitis in mice.Effects of rosmarinic acid on acetaminophen-induced hepatotoxicity in male Wistar rats.Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions.
P2860
A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity.
@ast
A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity.
@en
type
label
A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity.
@ast
A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity.
@en
prefLabel
A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity.
@ast
A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity.
@en
P2093
P2860
P356
P1476
A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity
@en
P2093
Jay Luther
Kevin R King
Martin L Yarmush
Matthew Li
Stefan Bohr
Suraj J Patel
P2860
P356
10.1038/CTG.2016.13
P577
2016-03-17T00:00:00Z